Mutual Pharmaceutical Company
Closed portfolio with an early-phase archive tilt
According to ClinicalTrials.gov-derived indexes, Mutual Pharmaceutical Company sits in the top decile of US sponsors by registered trial count (#583 of 15,742 sponsors by registered trial count).
Mutual Pharmaceutical Company: 27 sponsored US clinical trials, none currently recruiting.
Mutual Pharmaceutical Company sponsors 27 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 26 completed. 0 of these trials are in Phase 3-4 (later-stage) and 27 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Pharmacokinetics, with 2 trials.
Top-decile sponsor footprint
Mutual Pharmaceutical Company ranks in the top decile of sponsors by registered trial count (#583 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
26 of 27 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (96.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Indexed trials (enrollment closed)
27 total, page 1 of 1
A Drug-Drug Interaction Study Between Fenofibric Acid and Efavirenz
NCT01472380
Pharmacokinetics Study of Colchicine in Familial Mediterranean Fever (FMF) Patients
NCT01075906
Bioavailability Study of Colcrys® Crushed and Sprinkled on Applesauce
NCT01130051
Bioavailability Study of Colcrys® in Apple Juice
NCT01123395
Drug-Food Interaction Study of Seville Orange Juice and Colchicine
NCT00960193
Drug-Drug Interaction Study Between Colchicine and Atorvastatin
NCT00960323
A Drug-Food Interaction Study Between Colchicine and Grapefruit Juice
NCT00984009
Drug-Drug Interaction Between Colchicine and Verapamil ER
NCT00983242
Drug-Drug Interaction Study Between Quinine Sulfate and Rosiglitazone
NCT00785213
Drug-Drug Interaction Study of Colchicine and Theophylline
NCT00983905
Drug-Drug Interaction Study Between Colchicine and Cyclosporine
NCT00983931
Drug-Drug Interaction Study Between Colchicine and Diltiazem ER
NCT00983372
Drug-Drug Interaction Study Between Colchicine and Ketoconazole
NCT00983216
Drug-Drug Interaction Between Colchicine and Ritonavir
NCT00983515
Drug-Drug Interaction Study of Colchicine and Clarithromycin
NCT00984061
Pharmacokinetic and Exploratory Electrocardiogram (ECG) Study
NCT01018420
Four Arm Food Effect Study of Fenofibric Acid Tablets
NCT00960856
Comparative Study of Quinine Sulfate in Healthy Patients and in Patients With Renal Impairment
NCT00785551
Bioequivalence Study of Fenofibric Acid Versus Tricor® (Fenofibrate)
NCT00961116
Pharmacokinetic Study of an Acute Gout Regimen
NCT01017042
Pharmacokinetic Study With Colchicine in Healthy Volunteers
NCT01017003
Bioequivalence Study of Colchicine Tablets
NCT01021020
A Pharmacokinetic Study of Colchicine With an Oral Contraceptive
NCT01040845
Drug - Drug Interaction Study Between Quinine Sulfate and Theophylline
NCT00779259
Drug-Drug Interaction Study of Qualaquin and Midazolam
NCT00785486
Fed Bioavailability Study of Zonisamide Capsules
NCT00687167
A Relative Bioavailability Study of Quinine Sulfate Capsules Under Fasting and Fed Conditions
NCT00727272
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 27 |
Therapeutic Areas
How the Mutual Pharmaceutical Company early-phase archive is shaped
27 indexed studies, none listed as recruiting (0% open); 26 completed (96%).
Phase mix: 0 late (III/IV) vs 27 early (I/II) (early-phase heavy).
Top condition: Pharmacokinetics (2 trials), 2 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Mutual Pharmaceutical Company: archived-pipeline peers nationwide
Peers matched on 27 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Mutual Pharmaceutical Company sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 27 archived trials
- Akron Children's Hospital · 27 trials · 7% recruiting
- ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) · 27 trials · 0% recruiting
- AVEO Pharmaceuticals · 27 trials · 7% recruiting
- Dompé Farmaceutici S.p.A · 27 trials · 15% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Mutual Pharmaceutical Company page
27 registered trials is a research-attention snapshot, not an endorsement of Mutual Pharmaceutical Company or any single study.
- None of Mutual Pharmaceutical Company's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Pharmacokinetics is the condition Mutual Pharmaceutical Company studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Pharmacokinetics trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Mutual Pharmaceutical Company pipeline card: 27 registered trials from official public datasets.Report a data error.